Organ-specific responses to plutonium exposure have been identified, offering insight into new approaches for pharmaceutical countermeasure design and treatment
Rebecca Abergel, Ph.D. and coworkers at Lawrence Berkeley National Laboratory have determined the ways in which gadolinium disrupts the normal function of cells
Co-founder and CEO Julian Rees, Ph.D. discusses a shift in HOPO’s focus area in last week’s newsletter READ
The UC Berkeley-based startup incubator / accelerator provides a vast network of resources, contacts, and guidance to help us achieve our mission
Rebecca Abergel, Ph.D. and Julian Rees, Ph.D. have received a Bakar Fellowship from UC Berkeley to advance the commercial development of our heavy metal chelator 3,4,3,-LI(1,2-HOPO)
Huge congratulations to co-founder Rebecca Abergel, Ph.D. on her promotion to Associate Professor with tenure!
Co-founder and CEO Julian Rees, Ph.D. sent a letter yesterday with important company news and updates - you can read it here. Join our mailing list to stay on top of more news!